CARCINOGENICITY ASSESSMENT OF ALDRIN AND DIELDRIN
Notice - This site contains archived material(s)
Archive disclaimer
Archive
disclaimer
Archived files are provided for reference
purposes only. These files are no longer maintained by the Agency and may be outdated. For
current EPA information, go to www.epa.gov. It is EPA's policy to
support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation
Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact
EPA's Reasonable Accommodations
or submit a request using the Contact Us form.
Abstract
Evidence pertaining to the carcinogenicity of aldrin/dieldrin is reviewed and evaluated. The report covers studies completed before 1985. Case reports and epidemiologic studies of pesticide applicators and pesticide manufacturing workers are reviewed, but because of methodologic limitations, these studies established neither a positive nor a negative association between cancer and aldrin/dieldrin exposure. A number of independent studies of laboratory animals, however, demonstrated that aldrin/dieldrin cause liver cancer in mice and rats. Based on the accumulated evidence, aldrin/dieldrin are classified as probable human carcinogens, Group B2, using EPA's Guidelines for Carcinogen Risk Assessment. The carcinogenic potency of aldrin/dieldrin is estimated by fitting mathematical models to the laboratory animal data. These estimates indicate that aldrin/dieldrin are rather potent carcinogens, ranking in the second quartile of potential carcinogens evaluated by EPA's Carcinogen Assessment Group.
Citation
Cavender, F., B. Cook, N. Page, V. Cogliano, AND N. Hajjar. CARCINOGENICITY ASSESSMENT OF ALDRIN AND DIELDRIN. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/6-87/006 (NTIS PB88139951).
Additional Information
Prepared in cooperation with Dynamac Corp., Rockville, MD.